Can We Afford the Future of Medicine? The Promise and Price of Cell and Gene Therapies

icon mic

September 21, 2026

The promise of cell and gene therapies is big. They have the ability to address the underlying genetic causes of disease, offering new possibilities for people with serious and previously difficult-to-treat conditions. But as cell and gene therapies move beyond just treating rare diseases to also address conditions such as high cholesterol, the market is being shaped by new questions about access and value. The evidence base for existing therapies also continues to evolve, particularly as researchers assess long-term outcomes for treatments that are often approved based on small patient datasets.

Sarah Emond, President and CEO of the Institute for Clinical and Economic Review (ICER), returns to the Business Group on Health podcast to discuss what has changed in the cell and gene therapy market. The conversation explores evolving evidence, how therapies are priced and paid for, provider capacity, regulatory developments, and the long-term durability of treatment outcomes.

As the number of people who become eligible for cell and gene therapies grows, employers face the challenge of connecting employees and their families to potentially life-changing therapies, while also assessing value and managing financial risk.

Tune in for practical insights into new developments, emerging payment options and how stakeholders across the healthcare ecosystem can work together to balance innovation, access and affordability.

SPEAKERS

Sarah Emond | President and CEO, Institute for Clinical and Economic Review (ICER)

Ellen Kelsay | President and CEO, Business Group on Health

Download Transcript 

Duration 33 min

Subscribe To The Podcast

All Podcasts

Showing items 71-80 of 132
May 15, 2023
Life Expectancy is Decreasing: Investigating the...
U.S. life expectancy has worsened in the last decade- Dr. Steven Woolf tells us why. Listen to our podcast to learn about how we...
Read more
Apr 28, 2023
Why the Message and Messenger Matter: Improving...
If health literacy is a social determinant of health, why isn’t it prioritized more broadly by those in the health care system?...
Read more
Apr 17, 2023
Bringing Care Outside the Hospital and Into the...
What if instead of going to the hospital when we became sick, the hospital came to us? That’s the topic of today’s Business Group...
Read more
Mar 27, 2023
Friends at Work: Why Connecting with Colleagues is...
On this episode of the Business Group on Health podcast, we speak with author Shasta Nelson on how employers can recognize the...
Read more
Mar 13, 2023
Transforming the End-of-Life Experience with Death...
We delve deeper into death doulas and the role they play with Alua Arthur, founder of Going with Grace, an organization that seeks...
Read more
Feb 27, 2023
The Crucial Role of Doulas for Black Birthing...
On this episode of the Business Group on Health podcast, we discuss how birth doulas can help mitigate the high mortality rates...
Read more
Feb 13, 2023
What’s Behind the Youth Mental Health Crisis?
On this episode of the Business Group on Health podcast, we dig deeper into why children today are experiencing acute mental...
Read more
Jan 23, 2023
The Truth about Eating Disorders
At least one in ten people will be diagnosed with an eating disorder in their lifetime. Despite how common they are, most of us...
Read more
Jan 09, 2023
Cancer and Careers: Moving Forward Without Fear
On this episode of the Business Group on Health podcast, we talk with Rebecca Nellis, executive director of Cancer and Careers,...
Read more
Nov 28, 2022
Envisioning a World Free of HIV
The United Nations has an ambitious goal for the world: to end the AIDS epidemic by 2030.
Read more
Showing items 71-80 of 132